Activity value 81china Buyer&Supplier,Last transaction date:
2026-03-31
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zhejiang guobang pharma co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 256 transactions, with a transaction quantity of 251323 and a transaction weight of 84885.9.
Product description
CLARITHROMYCIN Current USP (Dược chất sản xuất thuốc; 25kg/ thùng); Số lô: 128-260209-1; NSX: T03/2026-HSD:T03/2031. Hàng mới 100%
Expand
Trade date
2026/03/30
B/L No.
——
Suppliers
zhejiang guobang pharma co.ltd.
Buyers
sami pharmaceutical pvt ltd.
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
28547.19097
Hs code
29334950
Product tags
pharmaceutical raw material,moxifloxacin hcl
Product description
PHARMACEUTICAL RAW MATERIAL MOXIFLOXACIN HCL
Expand
4ajanta pharma ltd.
united statesbuyer,they trade on 2026-02-25
1701.72%
>
5pratistha pharma
indiabuyer,they trade on 2023-06-02
1701.72%
>
+View All
Products
Total 338
ProductsTransactionsPerDetail
pharmaceutical raw material 60627.62%>
clarithromycin 32414.77%>
p4 22710.35%>
azithromycin dihydrate 22410.21%>
azithromycin 22310.16%>
+View All
Hscode rank
Total 225
HSCode NameTransactionsPerDetail
HS 2941909047121.47%>
HS 2941500040518.46%>
HS 2933599038417.5%>
HS 293359301295.88%>
HS 293349501225.56%>
+View All
Trading Area
Total 31
AreaTransactionsPerDetail
pakistan322532.54%>
india270627.30%>
vietnam140114.14%>
bangladesh4414.45%>
peru3783.81%>
+View All
Port statistics
Total 72
Port NameTransactionsPerDetail
shanghai143814.51%>
shanghai cn2182.20%>
singapore350.35%>
ningbo340.34%>
hangzhou280.28%>
+View All
zhejiang guobang pharma co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,clarithromycin,p4.
According to the 52wmb.com global trade database, as of 2026-03-31, the company has completed 9911 international trades,
with its main trading regions covering pakistan,india,vietnam etc.
The core products include HS29419090,HS29415000,HS29335990 etc,
often transported via shanghai,port shanghai cn, port singapore etc,
and its main trading partners are sami pharmaceuticals pvt ltd.,central de productos quimicos de cv,dresden lab s.a.c..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zhejiang guobang pharma co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.